The Year 2022 in Cardiovascular Diseases- Clinics and Practice

[...]appropriate and adequate thromboprophylaxis is critical for VTE prevention in COVID-19. [6] analyzed the effect of hydroxychloroquine or chloroquine associated with azithromycin on the QTc interval in 224 patients treated for COVID-19 at the Libreville University Hospital Center in Gabon. RHI did not show any significant improvement during the initial six months, and only slightly improved by the third month (p = 0.063). [...]in this study the authors did not observe a significant positive effect on arteriosclerosis index or blood pressure, although the compliance with this stretching program, evaluated by the exercise implementation rate for the entire period, was 90% or more. After the implant, the patient demonstrated a marked improvement in exercise effort and quality of life (QOL), assessed with a six-minute walk test, the Minnesota Living with Heart Failure Questionnaire, and echocardiographic parameters.